Detailed Information on Publication Record
2023
Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine
SVEDMYR, Sven, Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI et. al.Basic information
Original name
Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine
Authors
SVEDMYR, Sven (guarantor), Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI, Ondřej LUDKA (203 Czech Republic, belonging to the institution), Ding ZOU and Ludger GROTE
Edition
Journal of Sleep Research, HOBOKEN, WILEY, 2023, 0962-1105
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30210 Clinical neurology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.400 in 2022
RIV identification code
RIV/00216224:14110/23:00130273
Organization unit
Faculty of Medicine
UT WoS
000899297400001
Keywords in English
antihypertensive treatment; beta-blocker; blood pressure control; diuretic; hypertension; obstructive sleep apnea
Tags
International impact, Reviewed
Změněno: 15/11/2023 07:41, Mgr. Tereza Miškechová
Abstract
V originále
We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged males with hypertension. Conversely, the combination of a beta-blocker and a diuretic was associated with lower systolic and diastolic blood pressure in patients with hypertension with moderate-severe OSA. Systolic blood pressure was better controlled in female patients using this combined treatment. Our cross-sectional data suggest that specific clinical characteristics and type of antihypertensive medication influence the degree of blood pressure control in patients with hypertension with OSA. Controlled trials are warranted.